
Reviewer Board
Members of the reviewer board are selected from all Cancers reviewers for regularly providing timely high quality reports on submitted manuscripts. Responsibilities of reviewers are available here.
Members
Interests: Pediatric high risk solid tumors; high risk solid tumors (e.g., kidney cancers, soft tissue sarcomas and brain tumors). These cancers represent the areas of greatest need in Pediatric Oncology. His work uses functional genomic techniques (e.g. RNAi, CRISPR-Cas9) and the latest sequencing
Interests: molecular markers for drug resistance; molecular and immunohistochemical markers for cancer survival; molecular diagnosis employing next generation sequencing; molecular assay development for diagnosis; epigenetic mechanisms for drug resistance
Interests: Biliary Tract Cancer; pancreatic cancer and pNETs; liver tumours; liver metastases
Interests: role of notch signaling in triple negative breast cancer (TNBC); cancer cell metabolism; tumor infiltrating immune cells metabolism
Interests: liver; Chronic Hepatitis; Hepatocellular Carcinoma; NASH; zinc; cirrhosis
Interests: leukemia; lymphoma; multiple myeloma; bone marrow transplant; immune therapy
Interests: development biology; gene transcription and regulation; molecular tumorigenesis; immunotherapy
Interests: physiology; tumor biology; neuro-oncology; cellular and molecular biology; gene transcription; post-translational modification; tumor mouse models
Interests: glioma; Medulloblastoma; cancer stem cell; tumor microenvironment
Interests: prostate cancer; breast cancer; androgen receptor; molecular pharmacology; gene regulation; UDP-Glucanosyltransferases (UGTs); Splicing variant transcripts
Interests: lung; skin and esophageal carcinogenesis; tumor-associated inflammation and macrophages; fungal infection associated tumorigenesis; microbiota; transcriptome regulation; Ikka signaling; NF-kB Signaling
Interests: oral cavity cancer; salivary gland neoplasms; carcinogenesis; survival; susceptible genes; single nucleotide polymorphism
2. Graduate Institute of Health Industry Technology, Chang Gung University of Science and Technology, Taoyuan, Taiwan
Interests: lung cancer; colon cancer; tumor immunology; natural products; botanical drug development; traditional chinese medicine and acupuncture; the integration of modern and traditional medicine for health promotion
Interests: prostate cancer; metabolism; targeted therapy; nature products; signaling transduction
Interests: breast cancer; epigenetics; pharmacology; immunotherapy
Interests: cancer chemoprevention; skin cancer chemoprevention; lung cancer chemoprevention; natural product; Immunosuppression; ultraviolet radiation; carcinogenesis; transdermal drug delivery
Interests: influenza vaccine development; adenoviral gene therapy for ovarian cancer
Interests: radiation biology; anti-tumor immunity; data mining in cancer database
Interests: bone marrow; mesenchymal stem; stromal cells adipogenesis; tumor microenvironment; leukemia
2. Clinical Chemistry, Biochemistry and Molecular Biology Operations (UOC), Fondazione Policlinico A. Gemelli–IRCCS, Rome, Italy
Interests: proteomics; metabolomics; mass spectrometry
Interests: breast cancer; oncological surgery; metabolic derangements; nutritional derangements; adipositiy, sarcopenia
Interests: radiology; interventional radiology; interventional oncology
Interests: liver transplantation; hepatobiliary surgery; Hepatocellular Carcinoma; colorectal cancer; neuroendocrine tumour; Kidney Transplantation
Interests: melanoma; immunotherapy; targeted therapy; Kaposi sarcoma; non-melanoma skin cancer; NSCLC; thoracic tumors; gynecologic tumors
Interests: oncogene drivers; drug resistance to targeted therapies; cancer stem cells; EMT and molecular imaging in cancer
Interests: Hepatocellular Carcinoma; portal hypertension; hepatitis
Interests: lymphoma; Myeloma; cancer biomarkers; mechanism drug resistance; drug development; targeted therapy; precision medicine
Interests: DNA vaccines; cancer immunity; innate immunity
Interests: gene regulatory networks (GRNS) in development; gene deregulation in cancer; animal models for cancer and development; bioinformatic analysis of NGS data; patient-derived xenograft (PDX); paediatric cancers; somatic genomic alterations in patient tissue (i.e. cfDNA)
Interests: asthma; COPD; cancer; melanoma; PDAC; inflammation; polyamines; metabolism; autophagy; drug resistance; Lipid Metabolism; mitochondria